Last reviewed · How we verify
NCT04236193: SIRVA
Ultrasound and Immunological Findings in Patients With Shoulder Injury Related to Vaccine Administration (SIRVA)
trial testing Ultrasound Shoulder and Immunological Phenotyping by FACS in Shoulder Injury Related to Vaccine Administration in 30 participants. Completed in 31 December 2019.
30 November 2018
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 April 2018 |
| Primary completion | 30 November 2018 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Ultrasound Shoulder and Immunological Phenotyping by FACS
Conditions studied
- Shoulder Injury Related to Vaccine Administration — all drugs for Shoulder Injury Related to Vaccine Administration →
- Erosion, Localized — all drugs for Erosion, Localized →
Sponsor
University Hospital, Basel, Switzerland
Who can join
18 and older, any sex, with Shoulder Injury Related to Vaccine Administration or Erosion, Localized. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Accidental vaccine injection into adjunct shoulder structures can cause tissue damage, termed Shoulder injury related to vaccine administration (SIRVA). The immunopathological mechanisms and consequences of SIRVA are unknown. The study assesses the clinical and immunological consequences of an influenza vaccine if accidentally administered in periarticular space.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Chronic stage magnetic resonance imaging findings in patients with shoulder injury related to vaccine administration (SIRVA).
Donners R, Gehweiler J, Kovacs B, Breit HC, et al · · 2023 · cited 3× · PMID 37012390 · DOI 10.1007/s00256-023-04334-3
Verify or expand the search:
- PubMed search for NCT04236193
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04236193 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 22 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04236193.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing